Prevalence of Functional Limitation in COVID-19 Recovered Patients Using the Post COVID-19 Functional Status Scale

Pant, Pankaj; Joshi, Aishana; Basnet, Babin; Shrestha, Suraj; Bista, Navindra Raj; Bam, Niraj; Das, Santa Kumar

doi:10.31729/jnma.5980

Cited by 18 publications

(21 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, it might be hypothesised that despite the association between the PCFS Scale and health-related quality of life in patients post COVID-19 infection, both questionnaires are evaluating different aspects and are not interchangeable. The PCFS Scale could be used at the time of hospital discharge, and to monitor functional status after hospital discharge [ 50 ], which could potentially help clinicians to determine an appropriate treatment strategy at the early stages after COVID-19 infection [ 52 ]. Nevertheless, this only provides an indication about the functional status of these patients, and not the health-related quality of life.…”

Section: Discussionmentioning

confidence: 99%

Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?

Goudman

Smedt

Noppen

et al. 2021

JCM

View full text Add to dashboard Cite

Patients recovered from a COVID-19 infection often report vague symptoms of fatigue or dyspnoea, comparable to the manifestations in patients with central sensitisation. The hypothesis was that central sensitisation could be the underlying common aetiology in both patient populations. This study explored the presence of symptoms of central sensitisation, and the association with functional status and health-related quality of life, in patients post COVID-19 infection. Patients who were previously infected with COVID-19 filled out the Central Sensitisation Inventory (CSI), the Post-COVID-19 Functional Status (PCFS) Scale and the EuroQol with five dimensions, through an online survey. Eventually, 567 persons completed the survey. In total, 29.73% of the persons had a score of <40/100 on the CSI and 70.26% had a score of ≥40/100. Regarding functional status, 7.34% had no functional limitations, 9.13% had negligible functional limitations, 37.30% reported slight functional limitations, 42.86% indicated moderate functional limitations and 3.37% reported severe functional limitations. Based on a one-way ANOVA test, there was a significant effect of PCFS Scale group level on the total CSI score (F(4,486) = 46.17, p < 0.001). This survey indicated the presence of symptoms of central sensitisation in more than 70% of patients post COVID-19 infection, suggesting towards the need for patient education and multimodal rehabilitation, to target nociplastic pain.

show abstract

Section: Discussionmentioning

confidence: 99%

Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?

Goudman

Smedt

Noppen

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…Hussein M, et al (2021) conducted a study to assess the post COVID-19 functional status in Egypt and discovered that 80 percent of COVID-19 recovered cases have varying degrees of functional restrictions ranging from negligible (63.1 percent), slight (14.4 percent), moderate (2 percent), and severe (0.5 percent) based on PCFS and discovered that these restrictions were affected by age, gender, periodic influenza vaccination, smoking, duration since symptoms onset, and need for treatment (3). The most prevalent post-COVID symptoms described by COVID recovered patients include dyspnea, fatigue, cough, sleep difficulties or insomnia, depression or anxiety, muscle pain or headache palpitations, chest discomfort, thromboembolism, chronic kidney disease, and hair loss (4,5,6,9,10,11). Borghi-Silva A, Krishna AG, and Gracia-Araujo AS (2021) revealed in a study to analyze the impact of functional ability and physical activity in COVID-19 patients that post-COVID patients are more prone to dyspnea and fatigue, which may limit their performance of activities of daily living.…”

Section: Introductionmentioning

confidence: 99%

“…The univariable logistic regression analysis revealed a significant association between the onset of symptoms of muscle or joint pain and an increased risk of incomplete functional outcome OR 4.06, 95%CI 1.33-12.37) (12). Another study, conducted by Pant, P., et al (2021), on the prevalence of functional limitation in COVID-19 recovered patients at Tribhuvan University Teaching Hospital using the post-COVID-19 functional status scale, revealed that more than half of the patients (56.6 percent) reported having no functional limitation (grade 0), while 43.4 percent of patients (grade 1 to 4) reported having some degree of functional limitation(5). However, in this current study, post-covid functional limitation of samples revealed that 58 percent have negligible functional limitation, 24 percent have no functional limitation, 16 percent have slight functional limitation, 1% have moderate functional limitation, and 1% have severe functional limitation.…”

mentioning

confidence: 99%

Prevalence of functional limitation in COVID-19 recovered patients

Tom

Sonymol

2022

IJEHS

View full text Add to dashboard Cite

Background:The Coronavirus Disease-2019 manifested as a serious infectious disease that affected people of all ages and genders, particularly older patients with comorbidities. Patients who have recovered from COVID have serious restrictions. Aims:The purpose of this study was to determine the prevalence of post-COVID-19 functional status (PCFS) in patients and the relationship between post-COVID-19 functional status and selected demographic characteristics.Methods: This study employed a descriptive survey research design and a quantitative, non-experimental research approach. Data were obtained from 190 COVID-19 recovered patients admitted to an Indian quaternary hospital who met the inclusion criteria utilizing an online survey approach and a mobile app. Prior to the study, the institutional scientific and ethical committees approved it. The study's findings were analyzed using descriptive statistics and chisquare. Results:The percentage of demographic data is identified, and the post COVID functional limitation of samples shows that 58 percent have negligible functional limitation, 24 percent have no functional limitation, 16 percent have slight functional limitation, 1 percent have moderate functional limitation, and 1 percent have severe functional limitation. There was an association between PCFS and age, as well as PCFS and the COVID-19 group. Conclusion:Some COVID-19 survivors suffered functional difficulties after infection. The severity of the disease and its duration are important risk factors for the development of post-COVID-19 functional impairments. The study's findings assist healthcare professionals in improving their understanding of post-COPID functional status and providing appropriate care to post-COPID recovered patients.

show abstract

“…Early data suggest that SARS-CoV-2 infection has left persistent effects such as fatigue, dyspnoea, myalgia, arthralgia, reduced cardio respiratory endurance, decreased functional exercise capacity and exercise tolerance, thereby limiting quality of life. [6][7][8][9][10][11][12][13][14][15] All of these require long-term care and rehabilitation to regain functionality. Post-acute COVID-19 (Long COVID-19) is defined as persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms.…”

Section: Introductionmentioning

confidence: 99%

Global mapping of exercise interventions among COVID-19 survivors: protocol for a scoping review

et al. 2022

View full text Add to dashboard Cite

IntroductionThe COVID-19 pandemic has posed an unparalleled threat to all dimensions of human health and well-being. The Pan American Health Organization has acknowledged the crucial role of rehabilitation therapies for COVID-19 and emphasised the importance of exercise programmes for COVID-19 survivors. This scoping review outlines our strategy for systematically reviewing published and unpublished literature to investigate the volume of evidence for exercise interventions for COVID-19 survivors.Methods and analysisThis scoping review will be conducted based on the framework developed by Arksey and O'Malley. Six databases (PubMed/Medline, Scopus, Web of Science, Cochrane Central, ProQuest and CINAHL) will be searched in August 2022 and articles will be considered for inclusion published till July 2022. Studies will be screened by two independent reviewers at the title/abstract and full-text screening stages, as well as data extraction and critical assessment. Data will be extracted in a data extraction form and presented as figures and tables with narratives. This scoping review will give a thorough understanding of the current literature on exercise interventions for COVID-19 survivors, as well as identify knowledge gaps that will guide future research. Preliminary searches will be conducted after the publication of this scoping review protocol.Ethics and disseminationNo human or animal participants were involved in this review. Therefore, ethical committee approval is not required. Transparency will be followed at every review stage. Review findings will be disseminated through peer-review publications or through conference presentations.

show abstract

Prevalence of Functional Limitation in COVID-19 Recovered Patients Using the Post COVID-19 Functional Status Scale

Cited by 18 publications

References 18 publications

Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?

Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?

Prevalence of functional limitation in COVID-19 recovered patients

Global mapping of exercise interventions among COVID-19 survivors: protocol for a scoping review

Contact Info

Product

Resources

About